229 related articles for article (PubMed ID: 32914391)
1. A Pretargeted Imaging Strategy for EGFR-Positive Colorectal Carcinoma via Modulation of Tz-Radioligand Pharmacokinetics.
Qiu L; Lin Q; Si Z; Tan H; Liu G; Zhou J; Wang T; Chen Y; Huang Y; Yu T; Jin M; Cheng D; Shi H
Mol Imaging Biol; 2021 Feb; 23(1):38-51. PubMed ID: 32914391
[TBL] [Abstract][Full Text] [Related]
2. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
[TBL] [Abstract][Full Text] [Related]
3. CD11b-Based Pre-Targeted SPECT/CT Imaging Allows for the Detection of Inflammation in Aortic Aneurysm.
Zhou X; Zhu K; Zhang Y; Ming Y; Shi D; Tan H; Xiang B; Zhu S; Cheng D; Lai H; Wang C; Liu G
J Inflamm Res; 2022; 15():1921-1933. PubMed ID: 35321320
[TBL] [Abstract][Full Text] [Related]
4. Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.
Zeglis BM; Brand C; Abdel-Atti D; Carnazza KE; Cook BE; Carlin S; Reiner T; Lewis JS
Mol Pharm; 2015 Oct; 12(10):3575-87. PubMed ID: 26287993
[TBL] [Abstract][Full Text] [Related]
5. (99m)Tc-bioorthogonal click chemistry reagent for in vivo pretargeted imaging.
García MF; Zhang X; Shah M; Newton-Northup J; Cabral P; Cerecetto H; Quinn T
Bioorg Med Chem; 2016 Mar; 24(6):1209-15. PubMed ID: 26875936
[TBL] [Abstract][Full Text] [Related]
6. Targeting Infiltrating Myeloid Cells in Gastric Cancer Using a Pretargeted Imaging Strategy Based on Bio-Orthogonal Diels-Alder Click Chemistry and Comparison with
Zhang Y; Lin Q; Wang T; Shi D; Fu Z; Si Z; Xu Z; Cheng Y; Shi H; Cheng D
Mol Pharm; 2022 Jan; 19(1):246-257. PubMed ID: 34816721
[TBL] [Abstract][Full Text] [Related]
7. Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept.
Rondon A; Schmitt S; Briat A; Ty N; Maigne L; Quintana M; Membreno R; Zeglis BM; Navarro-Teulon I; Pouget JP; Chezal JM; Miot-Noirault E; Moreau E; Degoul F
Theranostics; 2019; 9(22):6706-6718. PubMed ID: 31588245
[No Abstract] [Full Text] [Related]
8. PEGylated and Non-PEGylated TCP-1 Probes for Imaging of Colorectal Cancer.
Liu Z; Gray BD; Barber C; Wan L; Furenlid LR; Liang R; Li Z; Woolfenden JM; Pak KY; Martin DR
Mol Imaging Biol; 2023 Feb; 25(1):133-143. PubMed ID: 34845659
[TBL] [Abstract][Full Text] [Related]
9. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a
Edem PE; Jørgensen JT; Nørregaard K; Rossin R; Yazdani A; Valliant JF; Robillard M; Herth MM; Kjaer A
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979070
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.
Ogawa K; Mukai T; Inoue Y; Ono M; Saji H
J Nucl Med; 2006 Dec; 47(12):2042-7. PubMed ID: 17138748
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Structurally Diverse
Adhikari K; Dewulf J; Vangestel C; Van der Veken P; Stroobants S; Elvas F; Augustyns K
ACS Omega; 2023 Oct; 8(41):38252-38262. PubMed ID: 37867688
[No Abstract] [Full Text] [Related]
13. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
[TBL] [Abstract][Full Text] [Related]
14. Pretargeted PET of Osteodestructive Lesions in Dogs.
Maitz CA; Delaney S; Cook BE; Genady AR; Hoerres R; Kuchuk M; Makris G; Valliant JF; Sadeghi S; Lewis JS; Hennkens HM; Bryan JN; Zeglis BM
Mol Pharm; 2022 Sep; 19(9):3153-3162. PubMed ID: 35635337
[TBL] [Abstract][Full Text] [Related]
15. Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41.
Welling MM; Visentin R; Feitsma HI; Lupetti A; Pauwels EK; Nibbering PH
Nucl Med Biol; 2004 May; 31(4):503-9. PubMed ID: 15093821
[TBL] [Abstract][Full Text] [Related]
16. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
[TBL] [Abstract][Full Text] [Related]
17. Kit formulation for preparation and biological evaluation of a novel (99m)Tc-oxo complex with metronidazole xanthate for imaging tumor hypoxia.
Li Z; Lin X; Zhang J; Wang X; Jin Z; Zhang W; Zhang Y
Nucl Med Biol; 2016 Feb; 43(2):165-70. PubMed ID: 26872441
[TBL] [Abstract][Full Text] [Related]
18. Click-Mediated Pretargeted Radioimmunotherapy of Colorectal Carcinoma.
Membreno R; Cook BE; Fung K; Lewis JS; Zeglis BM
Mol Pharm; 2018 Apr; 15(4):1729-1734. PubMed ID: 29502416
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and preclinical investigation of
Shah SQ; Gul-E-Raana
Mol Biol Rep; 2019 Apr; 46(2):1675-1682. PubMed ID: 30680596
[TBL] [Abstract][Full Text] [Related]
20. SPECT imaging of interleukin-6 receptor in ovarian tumor xenografts with a novel radiotracer of 99mTc-HYNIC-Aca-LSLITRL.
Li F; Zhang Z; Cheng T; Wei R; Dai Y; Lv M; Luo D; Zhu X; Ma D; Xi L; Dong Q; Ma X
Amino Acids; 2016 Jan; 48(1):91-101. PubMed ID: 26255282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
